0001786037-19-000002.txt : 20190909 0001786037-19-000002.hdr.sgml : 20190909 20190909123922 ACCESSION NUMBER: 0001786037-19-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190909 DATE AS OF CHANGE: 20190909 EFFECTIVENESS DATE: 20190909 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EIR Pharmaceuticals, LLC CENTRAL INDEX KEY: 0001786037 IRS NUMBER: 831613465 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-347715 FILM NUMBER: 191082493 BUSINESS ADDRESS: STREET 1: 1675 S STATE STREET STREET 2: SUITE B CITY: DOVER STATE: DE ZIP: 19901 BUSINESS PHONE: (515) 231-0874 MAIL ADDRESS: STREET 1: 1675 S STATE STREET STREET 2: SUITE B CITY: DOVER STATE: DE ZIP: 19901 D/A 1 primary_doc.xml X0708 D/A LIVE 0001786037 EIR Pharmaceuticals, LLC 1675 S STATE STREET SUITE B DOVER DE DELAWARE 19901 (515) 231-0874 DELAWARE None None Limited Liability Company true 2018 Andrew Skaff 10900 South Clay Blair Boulevard SUITE 1600 Olathe KS KANSAS 66061 Executive Officer Pharmaceuticals Decline to Disclose 06b true 0001786037-19-000001 2019-08-16 false true true SAFE (Simple Agreement Future Equity) false 1 Indefinite 70000 Indefinite false 3 0 0 0 false EIR Pharmaceuticals, LLC Andrew Skaff Andrew Skaff Manager 2019-09-09